Trade

with

IntelliPharmaCeutics International Inc
(NASDAQ: IPCI)
AdChoices
2.74
+0.02
+0.74%
After Hours :
-
-
-

Open

2.78

Previous Close

2.72

Volume (Avg)

74.36k (129.57k)

Day's Range

2.74-2.80

52Wk Range

1.63-6.46

Market Cap.

63.92M

Dividend Rate ( Yield )

-

Beta

1.34

Shares Outstanding

23.33M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 1.53M

    • Net Income

    • -11.50M

    • Market Cap.

    • 63.92M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -101.99

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.34

    • Forward P/E

    • 256.41

    • Price/Sales

    • 7.04

    • Price/Book Value

    • 11.44

    • Price/Cash flow

    • -27.47

      • EBITDA

      • -10.67M

      • Return on Capital %

      • -136.11

      • Return on Equity %

      • -424.75

      • Return on Assets %

      • -136.11

      • Book Value/Share

      • 0.24

      • Shares Outstanding

      • 23.33M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 11.00

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -0.03

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 42.05

            • 82.75

            • Pre-Tax Margin

            • -101.99

            • 39.38

            • Net Profit Margin

            • -101.99

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.01

              • 0.76

              • Current Ratio

              • 2.11

              • 2.92

              • Quick Ratio

              • 2.00

              • 2.35

              • Interest Coverage

              • -19.95

              • 38.02

              • Leverage Ratio

              • 1.61

              • 2.21

              • Book Value/Share

              • 0.24

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -6.91

                • 188.68

                • P/E Ratio 5-Year High

                • -16.28

                • 634.30

                • P/E Ratio 5-Year Low

                • -2.52

                • 124.82

                • Price/Sales Ratio

                • 7.04

                • 8.72

                • Price/Book Value

                • 11.44

                • 7.95

                • Price/Cash Flow Ratio

                • -27.47

                • 45.45

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -424.75

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -136.11

                    (-)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -236.59

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • 1.33

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -6.82M
                  Operating Margin
                  -446.40
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -27.47
                  Ownership

                  Institutional Ownership

                  13.07%

                  Top 10 Institutions

                  12.47%

                  Mutual Fund Ownership

                  9.07%

                  Float

                  71.23%

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Tekla Healthcare Investors

                  •  

                    828,360

                  • 0.00

                  • 3.54

                  • Tekla Life Sciences Investors

                  •  

                    575,640

                  • 0.00

                  • 2.46

                  • River and Mercantile World Recovery Fund

                  •  

                    408,231

                  • 0.00

                  • 1.77

                  • FCP OP MEDICAL BioHealthTrends

                  •  

                    164,360

                  • 0.00

                  • 0.68

                  • Cumbria Global Fund

                  •  

                    100,000

                  • 0.00

                  • 0.43

                  • PHARMA/wHEALTH

                  •  

                    28,316

                  • 0.00

                  • 0.12

                  • RIM Global CC Bioscience

                  •  

                    14,070

                  • 0.00

                  • 0.06

                  • Fidelity® NASDAQ Composite Index® Fund

                  •  

                    4,988

                  • 0.00

                  • 0.02

                  • CF Equities HAIG Pharma

                  •  

                    660

                  • 0.00

                  • 0.00

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Tekla Capital Management LLC

                  •  

                    1,404,000

                  • 0.00%

                  • 6.00

                  • River and Mercantile Asset Management

                  •  

                    408,231

                  • 0.00%

                  • 1.77

                  • Oppenheim Asset Mgmt Services S.à r.l.

                  •  

                    192,676

                  • -1.78%

                  • 0.82

                  • Morgan Stanley Smith Barney LLC

                  •  

                    176,432

                  • +36.68%

                  • 0.75

                  • Medical Strategy GmbH

                  •  

                    164,360

                  • 0.00%

                  • 0.68

                  • Balmoral Asset Management AG

                  •  

                    100,000

                  • 0.00%

                  • 0.43

                  • Morgan Stanley & Co Inc

                  •  

                    69,238

                  • +446.47%

                  • 0.30

                  • First Midwest Bank Trust Division

                  •  

                    48,342

                  • +3.53%

                  • 0.21

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  -

                  Style

                  Small Growth

                  IntelliPharmaCeutics International Inc was incorporated under the Canada Business Corporations Act by certificate and articles of arrangement dated October 22, 2009. The Company a pharmaceutical company specializing in the research, ...moredevelopment and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals. Based on this technology platform, they have developed several drug delivery systems and a pipeline of products and product candidates in various stages of development, including ANDAs filed with the FDA in therapeutic areas that include neurology, cardiovascul...morear, gastrointestinal tract (GIT), diabetes and pain. The Hypermatrix technologies are applied to the development of both existing and new pharmaceuticals across a range of therapeutic classes. Its scientists have developed drug delivery technology systems, based on the Hypermatrix platform, that facilitate controlled-release delivery of a wide range of pharmaceuticals. These systems include several core technologies, which enable them to flexibly respond to a wide range of drug attributes and patient requirements, producing a desired controlled-release effect. The platform of Hypermatrix drug delivery technologies include, but are not limited to, IntelliFoam, IntelliGITransporter, IntelliMatrix, IntelliOsmotics, IntelliPaste, IntelliPellets, IntelliShuttle and nPODDDS. The Company's competitors include medical technology, pharmaceutical, biotechnology and other companies, universities and research institutions. The sales of its products by its licensees outside the United States and Canada will be subject to regulatory requirements governing the testing, registration and marketing of pharmaceuticals, which vary widely from country to country.lessless

                  Key People

                  Dr. Isa Odidi

                  CEO/Chairman of the Board/Director

                  Mr. Shameze Rampertab

                  CFO/Vice President, Divisional

                  Mr. John N. Allport

                  Director/Vice President, Divisional

                  Dr. Patrick N. Yat

                  Vice President, Divisional

                  Dr. Eldon R. Smith,M.D.

                  Director

                  • IntelliPharmaCeutics International Inc

                  • 30 Worcester Road

                  • Toronto, ON M9W 5X2

                  • CAN.Map

                  • Phone: +1 416 798-3001

                  • Fax: +1 416 798-3007

                  • intellipharmaceutics.com

                  Incorporated

                  2009

                  Employees

                  38

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: